{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T20:07:06Z","timestamp":1725480426333},"publisher-location":"New York, NY","reference-count":92,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9780387308319"},{"type":"electronic","value":"9780387337784"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006]]},"DOI":"10.1007\/0-387-33778-4_13","type":"book-chapter","created":{"date-parts":[[2007,2,25]],"date-time":"2007-02-25T13:46:08Z","timestamp":1172411168000},"page":"209-218","source":"Crossref","is-referenced-by-count":9,"title":["Multiparameter Analysis of Immunogenetic Mechanisms in Clinical Diagnosis and Management of Inflammatory Bowel Disease"],"prefix":"10.1007","author":[{"given":"Jonathan","family":"Braun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan R.","family":"Targan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"26","key":"13_CR1","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1056\/NEJM199812243392607","volume":"339","author":"T.E. Starzl","year":"1998","unstructured":"Starzl TE, Zinkernagel RM. Mechanisms of Disease: Antigen localization and migration in immunity and tolerance. N Engl J Med 1998; 339(26):1905\u20131913.","journal-title":"N Engl J Med"},{"key":"13_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","volume":"20","author":"C.A. Janeway Jr","year":"2002","unstructured":"Janeway Jr CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20:197\u2013216.","journal-title":"Annu Rev Immunol"},{"key":"13_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0923-2494(98)80151-X","volume":"148","author":"R.B. Sartor","year":"1997","unstructured":"Sartor RB. The influence of normal microbial flora on the development of chronic mucosal inflammation. Res Immunol 1997; 148:567\u2013576.","journal-title":"Res Immunol"},{"key":"13_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1146\/annurev.immunol.20.100301.064816","volume":"20","author":"W. Strober","year":"2002","unstructured":"Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol 2002; 20:495\u2013549.","journal-title":"Annu Rev Immunol"},{"key":"13_CR5","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1126\/science.284.5418.1328","volume":"284","author":"A. Covacci","year":"1999","unstructured":"Covacci A, Telford JL, Del Giudice G et al. Helicobacter pylori virulence and genetic geography. Science 1999; 284:1328\u20131333.","journal-title":"Science"},{"issue":"3","key":"13_CR6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S1369-5274(02)00324-7","volume":"5","author":"V. Torsvik","year":"2002","unstructured":"Torsvik V, Ovreas L. Microbial diversity and function in soil: From genes to ecosystems. Curr Opin Microbiol 2002; 5(3):240\u2013245.","journal-title":"Curr Opin Microbiol"},{"issue":"2","key":"13_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1053\/gast.2003.50045","volume":"124","author":"D.K. Bonen","year":"2003","unstructured":"Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology 2003; 124(2):521\u2013536.","journal-title":"Gastroenterology"},{"issue":"6837","key":"13_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/35079107","volume":"411","author":"J.P. Hugot","year":"2001","unstructured":"Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease. Nature 2001; 411(6837):599\u2013603.","journal-title":"Nature"},{"issue":"6837","key":"13_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/35079114","volume":"411","author":"Y. Ogura","year":"2001","unstructured":"Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn\u2019s disease. Nature 2001; 411(6837):603\u2013606.","journal-title":"Nature"},{"issue":"5","key":"13_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nri1086","volume":"3","author":"N. Inohara","year":"2003","unstructured":"Inohara N, Nunez G. NODs: Intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 2003; 3(5):371\u2013382.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"13_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1053\/gast.2003.50019","volume":"124","author":"D.K. Bonen","year":"2003","unstructured":"Bonen DK, Ogura Y, Nicolae DL et al. Crohn\u2019s disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 2003; 124(1):140\u2013146.","journal-title":"Gastroenterology"},{"issue":"5","key":"13_CR12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1042\/cs0940473","volume":"94","author":"J. Satsangi","year":"1998","unstructured":"Satsangi J, Parkes M, Jewell DP et al. Genetics of inflammatory bowel disease. Clin Sci 1998; 94(5):473\u2013478.","journal-title":"Clin Sci"},{"issue":"4","key":"13_CR13","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1053\/gast.2002.32415","volume":"122","author":"A.P. Cuthbert","year":"2002","unstructured":"Cuthbert AP, Fisher SA, Mirza MM et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002; 122(4):867\u2013874.","journal-title":"Gastroenterology"},{"issue":"3","key":"13_CR14","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1053\/gast.2002.35393","volume":"123","author":"M.T. Abreu","year":"2002","unstructured":"Abreu MT, Taylor KD, Lin YC et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn\u2019s disease. Gastroenterology 2002; 123(3):679\u2013688.","journal-title":"Gastroenterology"},{"issue":"4","key":"13_CR15","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1053\/gast.2002.32413","volume":"122","author":"T. Ahmad","year":"2002","unstructured":"Ahmad T, Armuzzi A, Bunce M et al. The molecular classification of the clinical manifestations of Crohn\u2019s disease. Gastroenterology 2002; 122(4):854\u2013866.","journal-title":"Gastroenterology"},{"issue":"7","key":"13_CR16","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/S0016-5085(03)00385-8","volume":"124","author":"J. Halfvarson","year":"2003","unstructured":"Halfvarson J, Bodin L, Tysk C et al. Inflammatory bowel disease in a Swedish twin cohort: A long-term follow-up of concordance and clinical characteristics. Gastroenterology 2003; 124(7):1767\u20131773.","journal-title":"Gastroenterology"},{"issue":"4","key":"13_CR17","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1053\/gast.2003.50153","volume":"124","author":"T. Hisamatsu","year":"2003","unstructured":"Hisamatsu T, Suzuki M, Reinecker HC et al. CARD15\/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 2003; 124(4):993\u20131000.","journal-title":"Gastroenterology"},{"issue":"1","key":"13_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1086\/376417","volume":"73","author":"C. Giallourakis","year":"2003","unstructured":"Giallourakis C, Stoll M, Miller K et al. IBD5 is a general risk factor for inflammatory bowel disease: Replication of association with Crohn disease and identification of a novel association with ulcerative colitis. Am J Hum Genet 2003; 73(1):205\u2013211.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"13_CR19","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S0016-5085(98)70075-7","volume":"115","author":"M.E. Curran","year":"1998","unstructured":"Curran ME, Lau KF, Hampe J et al. Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology 1998; 115(5):1066\u20131071.","journal-title":"Gastroenterology"},{"issue":"2","key":"13_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/gut.49.2.311","volume":"49","author":"M. Parkes","year":"2001","unstructured":"Parkes M, Satsangi J, Jewell DP et al. Ulcerative colitis is more strongly linked to chromosome 12 than Crohn\u2019s disease. Gut 2001; 49(2):311.","journal-title":"Gut"},{"issue":"1","key":"13_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1046\/j.1365-2249.1997.4121510.x","volume":"109","author":"G. Bouma","year":"1997","unstructured":"Bouma G, Oudkerk P, Crusius JB et al. Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn\u2019s disease (CD). Clinical and Experimental Immunology 1997; 109(1):175\u2013179.","journal-title":"Clinical and Experimental Immunology"},{"issue":"1","key":"13_CR22","first-page":"226","volume":"59","author":"I. Naom","year":"1996","unstructured":"Naom I, Lee J, Ford D et al. Analysis of the contribution of HLA genes to genetic predisposition in inflammatory bowel disease. American Journal of Human Genetics 1996; 59(1):226\u2013233.","journal-title":"American Journal of Human Genetics"},{"issue":"2","key":"13_CR23","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1172\/JCI116613","volume":"92","author":"H.-Y. Yang","year":"1993","unstructured":"Yang H-Y, Rotter JI, Toyoda H et al. Ulcerative colitis: A genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. J Clin Invest 1993; 92(2):1080\u20131084.","journal-title":"J Clin Invest"},{"issue":"6","key":"13_CR24","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1053\/gast.2001.23966","volume":"120","author":"K.D. Taylor","year":"2001","unstructured":"Taylor KD, Plevy SE, Yang H et al. ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn\u2019s disease. Gastroenterology 2001; 120(6):1347\u20131355.","journal-title":"Gastroenterology"},{"issue":"3","key":"13_CR25","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1210\/jc.86.3.1306","volume":"86","author":"H. Ghanim","year":"2001","unstructured":"Ghanim H, Garg R, Aljada A et al. Suppression of nuclear factor-kappaB and stimulation of inhibitor kappaB by troglitazone: Evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese. J Clin Endocrinol Metab 2001; 86(3):1306\u20131312.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"13_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nm820","volume":"9","author":"S.B. Joseph","year":"2003","unstructured":"Joseph SB, Castrillo A, Laffitte BA et al. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 2003; 9(2):213\u2013219.","journal-title":"Nat Med"},{"issue":"5","key":"13_CR27","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/S0016-5085(03)00271-3","volume":"124","author":"L. Dubuquoy","year":"2003","unstructured":"Dubuquoy L, Jansson EA, Deeb S et al. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology 2003; 124(5):1265\u20131276.","journal-title":"Gastroenterology"},{"issue":"24","key":"13_CR28","doi-asserted-by":"publisher","first-page":"15451","DOI":"10.1073\/pnas.202604299","volume":"99","author":"T.S. Stappenbeck","year":"2002","unstructured":"Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci USA 2002; 99(24):15451\u201315455.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"13_CR29","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/00042737-200306000-00008","volume":"15","author":"K. Fellermann","year":"2003","unstructured":"Fellermann K, Wehkamp J, Herrlinger KR et al. Crohn\u2019s disease: A defensin deficiency syndrome? Eur J Gastroenterol Hepatol 2003; 15(6):627\u2013634.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"13_CR30","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1126\/science.270.5239.1203","volume":"270","author":"M.L. Hermiston","year":"1995","unstructured":"Hermiston ML, Gordon JI. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1995; 270:1203\u20131207.","journal-title":"Science"},{"issue":"10","key":"13_CR31","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.4049\/jimmunol.161.10.5733","volume":"161","author":"C.M. Panwala","year":"1998","unstructured":"Panwala CM, Jones JC, Viney JL. A novel model of inflammatory bowel disease: Mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol 1998; 161(10):5733\u20135744.","journal-title":"J Immunol"},{"issue":"1","key":"13_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1053\/gast.2003.50010","volume":"124","author":"M. Schwab","year":"2003","unstructured":"Schwab M, Schaeffeler E, Marx C et al. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology 2003; 124(1):26\u201333.","journal-title":"Gastroenterology"},{"issue":"8","key":"13_CR33","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0198-8859(99)00036-1","volume":"60","author":"B. Yacyshyn","year":"1999","unstructured":"Yacyshyn B, Maksymowych W, Bowen-Yacyshyn MB. Differences in P-glycoprotein-170 expression and activity between Crohn\u2019s disease and ulcerative colitis. Hum Immunol 1999; 60(8):677\u2013687.","journal-title":"Hum Immunol"},{"issue":"8","key":"13_CR34","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1111\/j.1572-0241.1999.01220.x","volume":"94","author":"T. Kakazu","year":"1999","unstructured":"Kakazu T, Hara J, Matsumoto T et al. Type 1 T-helper cell predominance in granulomas of Crohn\u2019s disease. Am J Gastroenterol 1999; 94(8):2149\u20132155.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"13_CR35","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1084\/jem.20011956","volume":"195","author":"M.F. Neurath","year":"2002","unstructured":"Neurath MF, Weigmann B, Finotto S et al. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn\u2019s disease. J Exp Med 2002; 195(9):1129\u20131143.","journal-title":"J Exp Med"},{"issue":"3","key":"13_CR36","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1053\/gast.2000.16500","volume":"119","author":"T. Dohi","year":"2000","unstructured":"Dohi T, Fujihashi K, Kiyono H et al. Mice deficient in Th1-and Th2-type cytokines develop distinct forms of hapten-induced colitis. Gastroenterology 2000; 119(3):724\u2013733.","journal-title":"Gastroenterology"},{"key":"13_CR37","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.4049\/jimmunol.157.3.1261","volume":"157","author":"I.J. Fuss","year":"1996","unstructured":"Fuss IJ, Neurath M, Boirivant M et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn\u2019s disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157:1261\u20131270.","journal-title":"J Immunol"},{"issue":"2","key":"13_CR38","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0002-9440(10)65128-0","volume":"155","author":"M. Uguccioni","year":"1999","unstructured":"Uguccioni M, Gionchetti P, Robbiani DF et al. Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. American Journal of Pathology 1999; 155(2):331\u2013336.","journal-title":"American Journal of Pathology"},{"issue":"10","key":"13_CR39","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1084\/jem.188.10.1929","volume":"188","author":"M. Boirivant","year":"1998","unstructured":"Boirivant M, Fuss IJ, Chu A et al. Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med 1998; 188(10):1929\u20131939.","journal-title":"J Exp Med"},{"issue":"1","key":"13_CR40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa020732","volume":"348","author":"S. Ghosh","year":"2003","unstructured":"Ghosh S, Goldin E, Gordon FH et al. Natalizumab for active Crohn\u2019s disease. N Engl J Med 2003; 348(1):24\u201332.","journal-title":"N Engl J Med"},{"key":"13_CR41","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/0016-5085(84)90084-2","volume":"87","author":"M.J. Blaser","year":"1984","unstructured":"Blaser MJ, Miller RA, Lacher J et al. Patients with active Crohn\u2019s disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology 1984; 87:888\u2013894.","journal-title":"Gastroenterology"},{"issue":"2","key":"13_CR42","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/00365528309181586","volume":"18","author":"I.O. Auer","year":"1983","unstructured":"Auer IO, Roder A, Wensinck F et al. Selected bacterial antibodies in Crohn\u2019s disease and ulcerative colitis. Scandinavian Journal of Gastroenterology 1983; 18(2):217\u2013223.","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"13_CR43","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/ard.51.12.1296","volume":"51","author":"S. O\u2019Mahony","year":"1992","unstructured":"O\u2019Mahony S, Anderson N, Nuki G et al. Systemic and mucosal antibodies to Klebsiella in patients with ankylosing spondylitis and Crohn\u2019s disease. Ann Rheum Dis 1992; 51:1296\u20131300.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"13_CR44","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1053\/gast.2002.31109","volume":"122","author":"J. Braun","year":"2002","unstructured":"Braun J. Unsettling facts of life: Bacterial commensalism, epithelial adherence, and inflammatory bowel disease. Gastroenterology 2002; 122(1):228\u2013230.","journal-title":"Gastroenterology"},{"key":"13_CR45","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/gut.31.5.536","volume":"31","author":"H. McKenzie","year":"1990","unstructured":"McKenzie H, Main J, Pennington CR et al. Antibody to selected strains of Saccharomyces cerevisiae (baker\u2019s and brewer\u2019s yeast) and Candida albicans in Crohn\u2019s disease. Gut 1990; 31:536\u2013538.","journal-title":"Gut"},{"key":"13_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000235217","volume":"92","author":"R.M.R. Barnes","year":"1990","unstructured":"Barnes RMR, Allan S, Taylor-robinson CH et al. Serum antibodies reactive with Saccharomyces cerevisiae in inflammatory bowel disease: Is IgA antibody a marker for Crohn\u2019s disease. Int Arch Allergy Appl Immunol 1990; 92:9\u201315.","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"13_CR47","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1128\/CDLI.3.2.219-226.1996","volume":"3","author":"B. Sendid","year":"1996","unstructured":"Sendid B, Colombel JF, Jacquinot PM et al. Specific antibody response to oligomannosidic epitopes in Crohn\u2019s disease. Clin Diag Lab Immunol 1996; 3:219\u2013226.","journal-title":"Clin Diag Lab Immunol"},{"key":"13_CR48","first-page":"147","volume":"35","author":"I.W. Davidson","year":"1979","unstructured":"Davidson IW, Lloyd RS, Whorewell PJ et al. Antibodies to maize in patients with Crohn\u2019s disease, ulcerative colitis, and coeliac disease. Clin Exp Immunol 1979; 35:147\u2013148.","journal-title":"Clin Exp Immunol"},{"key":"13_CR49","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1136\/gut.31.9.1037","volume":"31","author":"A. Sonnenberg","year":"1990","unstructured":"Sonnenberg A. Occupational distribution of inflammatory bowel disease among German employees. Gut 1990; 31:1037\u20131040.","journal-title":"Gut"},{"issue":"6","key":"13_CR50","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1136\/gut.42.6.788","volume":"42","author":"J.F. Quinton","year":"1998","unstructured":"Quinton JF, Sendid B, Reumaux D et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: Prevalence and diagnostic role. Gut 1998; 42(6):788\u2013791.","journal-title":"Gut"},{"key":"13_CR51","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1136\/gut.46.1.58","volume":"46","author":"C. Sutton","year":"2000","unstructured":"Sutton C, Yang H-Y, Rotter JI et al. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies (ASCA) in affected and unaffected relatives of Crohn\u2019s disease patients. Gut 2000; 46:58\u201363.","journal-title":"Gut"},{"key":"13_CR52","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1128\/JCM.30.8.2013-2018.1992","volume":"30","author":"L.G. Wayne","year":"1992","unstructured":"Wayne LG, Hollander D, Anderson B et al. Immunoglobulin A (IgA) and IgG serum antibodies to mycobacterial antigens in Crohn\u2019s disease patients and their relatives. J Clin Microbiol 1992; 30:2013\u20132018.","journal-title":"J Clin Microbiol"},{"key":"13_CR53","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/CDLI.1.2.241-243.1994","volume":"1","author":"P. Vannuffel","year":"1994","unstructured":"Vannuffel P, Dieterich C, Naerhuyzen B et al. Occurrence, in Crohn\u2019s disease, of antibodies directed against a species-specific recombinant polypeptide of Mycobacterium paratuberculosis. Clin Diag Lab Immunol 1994; 1:241\u2013243.","journal-title":"Clin Diag Lab Immunol"},{"key":"13_CR54","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-2249.1992.tb05874.x","volume":"90","author":"A. Elsaghier","year":"1992","unstructured":"Elsaghier A, Prantera C, Moreno C et al. Antibodies to Mycobacterium paratuberculosis-specific protein antigens in Crohn\u2019s disease. Clin Exp Immunol 1992; 90:503\u2013508.","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"13_CR55","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1023\/A:1026692627460","volume":"44","author":"K. Suenaga","year":"1999","unstructured":"Suenaga K, Yokoyama Y, Nishimori I et al. Serum antibodies to Mycobacterium paratuberculosis in patients with Crohn\u2019s disease. Dig Dis Sci 1999; 44(6):1202\u20131207.","journal-title":"Dig Dis Sci"},{"key":"13_CR56","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1128\/IAI.67.12.6510-6517.1999","volume":"67","author":"O. Cohavy","year":"1999","unstructured":"Cohavy O, Harth G, Horwitz MA et al. Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum IgA from patients with Crohn\u2019s disease. Infect Immun 1999; 67:6510\u20136517.","journal-title":"Infect Immun"},{"issue":"2","key":"13_CR57","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s002849900430","volume":"39","author":"F.A. Zaatari El","year":"1999","unstructured":"El Zaatari FA, Naser SA, Hulten K et al. Characterization of Mycobacterium paratuberculosis p36 antigen and its seroreactivities in Crohn\u2019s disease. Curr Microbiol 1999; 39(2):115\u2013119.","journal-title":"Curr Microbiol"},{"issue":"3\u20134","key":"13_CR58","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0378-1135(00)00334-5","volume":"77","author":"S.A. Naser","year":"2000","unstructured":"Naser SA, Hulten K, Shafran I et al. Specific seroreactivity of Crohn\u2019s disease patients against p35 and p36 antigens of M. avium subsp. paratuberculosis. Vet Microbiol 2000; 77(3\u20134):497\u2013504.","journal-title":"Vet Microbiol"},{"issue":"12","key":"13_CR59","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1128\/JCM.38.12.4373-4381.2000","volume":"38","author":"M.T. Collins","year":"2000","unstructured":"Collins MT, Lisby G, Moser C et al. Results of multiple diagnostic tests for Mycobacterium avium subsp. Paratuberculosis in patients with inflammatory bowel disease and in controls. J Clin Microbiol 2000; 38(12):4373\u20134381.","journal-title":"J Clin Microbiol"},{"key":"13_CR60","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1128\/IAI.68.3.1542-1548.2000","volume":"68","author":"O. Cohavy","year":"2000","unstructured":"Cohavy O, Bruckner D, Eggena ME et al. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect Immun 2000; 68:1542\u20131548.","journal-title":"Infect Immun"},{"issue":"10","key":"13_CR61","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.1128\/IAI.69.10.6044-6054.2001","volume":"69","author":"B. Wei","year":"2001","unstructured":"Wei B, Dalwadi H, Gordon LK et al. Molecular cloning of a Bacteroides caccae TonB-linked outer membrane protein associated with inflammatory bowel disease. Infect Immun 2001; 69(10):6044\u20136054.","journal-title":"Infect Immun"},{"issue":"3","key":"13_CR62","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1053\/gast.2002.35379","volume":"123","author":"C.J. Landers","year":"2002","unstructured":"Landers CJ, Cohavy O, Misra R et al. Selected loss of tolerance evidenced by Crohn\u2019s disease-associated immune responses to auto-and microbial antigens. Gastroenterology 2002; 123(3):689\u2013699.","journal-title":"Gastroenterology"},{"key":"13_CR63","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1053\/gast.2000.8519","volume":"119","author":"C.L. Sutton","year":"2000","unstructured":"Sutton CL, Kim J, Yamane A et al. Identification of a novel bacterial sequence associated with Crohn\u2019s disease. Gastroenterology 2000; 119:23\u201328.","journal-title":"Gastroenterology"},{"issue":"12","key":"13_CR64","doi-asserted-by":"publisher","first-page":"6567","DOI":"10.1128\/IAI.70.12.6567-6575.2002","volume":"70","author":"B. Wei","year":"2002","unstructured":"Wei B, Huang T, Dalwadi H et al. Pseudomonas fluorescens Encodes the Crohn\u2019s Disease-Associated I2 Sequence and T-Cell Superantigen. Infect Immun 2002; 70(12):6567\u20136575.","journal-title":"Infect Immun"},{"issue":"1","key":"13_CR65","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1074-7613(01)00164-9","volume":"15","author":"H. Dalwadi","year":"2001","unstructured":"Dalwadi H, Wei B, Kroenberg M et al. The Crohn\u2019s disease-associated bacterial protein I2 is a novel enteric T cell superantigen. Immunity 2001; 15(1):149\u2013158.","journal-title":"Immunity"},{"issue":"6","key":"13_CR66","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1136\/gut.44.6.812","volume":"44","author":"R. Duchmann","year":"1999","unstructured":"Duchmann R, May E, Heike M et al. T cell specificity and cross reactivity towards enterobacteria, Bacteroides, Bifidobacterium, and antigens from resident intestinal flora in humans. Gut 1999; 44(6):812\u2013818.","journal-title":"Gut"},{"issue":"6","key":"13_CR67","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMra020831","volume":"347","author":"D.K. Podolsky","year":"2002","unstructured":"Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347(6):417\u2013429.","journal-title":"N Engl J Med"},{"issue":"2","key":"13_CR68","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1053\/gast.2001.27154","volume":"121","author":"K.A. Papadakis","year":"2001","unstructured":"Papadakis KA, Prehn J, Moreno ST et al. CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn\u2019s disease. Gastroenterology 2001; 121(2):246\u2013254.","journal-title":"Gastroenterology"},{"issue":"7","key":"13_CR69","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1172\/JCI17244","volume":"111","author":"E.J. Kunkel","year":"2003","unstructured":"Kunkel EJ, Kim CH, Lazarus NH et al. CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J Clin Invest 2003; 111(7):1001\u20131010.","journal-title":"J Clin Invest"},{"issue":"8","key":"13_CR70","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI16432","volume":"111","author":"I. Tiede","year":"2003","unstructured":"Tiede I, Fritz G, Strand S et al. CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J Clin Invest 2003; 111(8):1133\u20131145.","journal-title":"J Clin Invest"},{"issue":"2","key":"13_CR71","first-page":"81","volume":"3","author":"S.B. Hanauer","year":"2003","unstructured":"Hanauer SB, Present DH. The state of the art in the management of inflammatory bowel disease. Rev Gastroenterol Disord 2003; 3(2):81\u201392.","journal-title":"Rev Gastroenterol Disord"},{"issue":"4","key":"13_CR72","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1053\/gast.2002.32420","volume":"122","author":"M.C. Dubinsky","year":"2002","unstructured":"Dubinsky MC, Yang H, Hassard PV et al. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology 2002; 122(4):904\u2013915.","journal-title":"Gastroenterology"},{"issue":"4\u20135","key":"13_CR73","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0171-2985(11)80509-7","volume":"181","author":"J.A. Rump","year":"1990","unstructured":"Rump JA, Scholmerich J, Gross V et al. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn\u2019s disease. Immunobiology 1990; 181(4\u20135):406\u2013413.","journal-title":"Immunobiology"},{"key":"13_CR74","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/0016-5085(91)90657-7","volume":"100","author":"R.H. Duerr","year":"1991","unstructured":"Duerr RH, Targan SR, Landers CJ et al. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides\/diarrheal illnesses. Gastroenterology 1991; 100:1590\u20131596.","journal-title":"Gastroenterology"},{"key":"13_CR75","first-page":"979","volume":"147","author":"P. Billing","year":"1995","unstructured":"Billing P, Tahir S, Calfin B et al. Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies. Am J Pathol 1995; 147:979\u2013987.","journal-title":"Am J Pathol"},{"key":"13_CR76","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF01541319","volume":"15","author":"A. Vidrich","year":"1995","unstructured":"Vidrich A, Lee J, James E et al. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: Ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis. J Clin Immunol 1995; 15:293\u2013299.","journal-title":"J Clin Immunol"},{"issue":"8","key":"13_CR77","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1023\/A:1018832608899","volume":"42","author":"C. Folwaczny","year":"1997","unstructured":"Folwaczny C, Noehl N, Endres SP et al. Antinuclear autoantibodies in patients with inflammatory bowel disease \u2014 High prevalence in first-degree relatives. Dig Dis Sci 1997; 42(8):1593\u20131597.","journal-title":"Dig Dis Sci"},{"key":"13_CR78","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1006\/jaut.1999.0340","volume":"14","author":"M. Eggena","year":"2000","unstructured":"Eggena M, Cohavy O, Parseghian M et al. Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA. J Autoimmunity 2000; 14:83\u201397.","journal-title":"J Autoimmunity"},{"key":"13_CR79","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1006\/clin.1995.1162","volume":"77","author":"D. Reumaux","year":"1995","unstructured":"Reumaux D, Meziere C, Colombel J-F et al. Distinct production of autoantibodies to nuclear components in ulcerative colitis and in Crohn\u2019s disease. Clin Immunol Immunopathol 1995; 77:349\u2013357.","journal-title":"Clin Immunol Immunopathol"},{"issue":"6","key":"13_CR80","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1136\/gut.44.6.867","volume":"44","author":"J. Sobajima","year":"1999","unstructured":"Sobajima J, Ozaki S, Uesugi H et al. High mobility group (HMG) nonhistone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis. Gut 1999; 44(6):867\u2013873.","journal-title":"Gut"},{"issue":"7","key":"13_CR81","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","volume":"110","author":"H. Xiao","year":"2002","unstructured":"Xiao H, Heeringa P, Hu P et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002; 110(7):955\u2013963.","journal-title":"J Clin Invest"},{"key":"13_CR82","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1023\/A:1018839306367","volume":"42","author":"D. Aldebert","year":"1997","unstructured":"Aldebert D, Masy E, Reumaux D et al. Immunoglobulin G subclass distribution of anti-endothelial cell antibodies (AECA) in patients with ulcerative colitis and Crohn\u2019s disease. Dig Dis Sci 1997; 42:2350\u20132355.","journal-title":"Dig Dis Sci"},{"key":"13_CR83","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/BF01316494","volume":"38","author":"T.R. Stevens","year":"1993","unstructured":"Stevens TR, Harley SL, Groom JS et al. Anti-endothelial cell antibodies in inflammatory bowel disease. Dig Dis Sci 1993; 38:426\u2013432.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"13_CR84","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1136\/gut.36.6.887","volume":"36","author":"P. Yang","year":"1995","unstructured":"Yang P, Jarnerot G, Danielsson D et al. P-ANCA in monozygotic twins with inflammatory bowel disease. Gut 1995; 36(6):887\u2013890.","journal-title":"Gut"},{"key":"13_CR85","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1600-065X.1999.tb01316.x","volume":"169","author":"A.K. Bhan","year":"1999","unstructured":"Bhan AK, Mizoguchi E, Smith RN et al. Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunol Rev 1999; 169:195\u2013207.","journal-title":"Immunol Rev"},{"issue":"1","key":"13_CR86","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/00054725-199802000-00004","volume":"4","author":"J. Satsangi","year":"1998","unstructured":"Satsangi J, Landers CJ, Welsh KI et al. The presence of anti-neutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel disease. Inflamm Bowel Dis 1998; 4(1):18\u201326.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"13_CR87","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/gut.47.4.487","volume":"47","author":"E.A. Vasiliauskas","year":"2000","unstructured":"Vasiliauskas EA, Kam LY, Karp LC et al. Marker antibody expression stratifies Crohn\u2019s disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 2000; 47(4):487\u2013496.","journal-title":"Gut"},{"key":"13_CR88","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/0003-4819-110-10-786","volume":"110","author":"C. Fiocchi","year":"1989","unstructured":"Fiocchi C, Roche JK, Michener WM. High prevalence of antibodies to intestinal epithelial antigens in patients with inflammatory bowel disease and their relatives. Ann Int Med 1989; 110:786\u2013794.","journal-title":"Ann Int Med"},{"key":"13_CR89","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/0016-5085(89)90406-X","volume":"97","author":"P. Brandtzaeg","year":"1989","unstructured":"Brandtzaeg P, Halstensen TS, Kett K et al. Immunobiology and immunopathology of human gut mucosa: Humoral immunity and intraepithelial lymphocytes. Gastroenterology 1989; 97:1562\u20131584.","journal-title":"Gastroenterology"},{"issue":"5","key":"13_CR90","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/S0016-5085(98)70310-5","volume":"114","author":"X. Geng","year":"1998","unstructured":"Geng X, Biancone L, Dai HH et al. Tropomyosin isoforms in intestinal mucosa: Production of autoantibodies to tropomyosin isoforms in ulcerative colitis. Gastroenterology 1998; 114(5):912\u2013922.","journal-title":"Gastroenterology"},{"issue":"2","key":"13_CR91","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1136\/gut.47.2.236","volume":"47","author":"S. Sakamaki","year":"2000","unstructured":"Sakamaki S, Takayanagi N, Yoshizaki N et al. Autoantibodies against the specific epitope of human tropomyosin(s) detected by a peptide based enzyme immunoassay in sera of patients with ulcerative colitis show antibody dependent cell mediated cytotoxicity against HLA-DPw9 transfected L cells. Gut 2000; 47(2):236\u2013241.","journal-title":"Gut"},{"issue":"1","key":"13_CR92","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1046\/j.1365-3083.2000.00759.x","volume":"52","author":"L. Ohman","year":"2000","unstructured":"Ohman L, Franzen L, Rudolph U et al. Immune activation in the intestinal mucosa before the onset of colitis in Galphai2-deficient mice. Scand J Immunol 2000; 52(1):80\u201390.","journal-title":"Scand J Immunol"}],"container-title":["Advances in Experimental Medicine and Biology","Immune Mechanisms in Inflammatory Bowel Disease"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/0-387-33778-4_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T19:47:24Z","timestamp":1683748044000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/0-387-33778-4_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"ISBN":["9780387308319","9780387337784"],"references-count":92,"URL":"https:\/\/doi.org\/10.1007\/0-387-33778-4_13","relation":{},"ISSN":["0065-2598"],"issn-type":[{"type":"print","value":"0065-2598"}],"subject":[],"published":{"date-parts":[[2006]]}}}